(Q40784250)

23 September 2017

Specific killing of P53 mutated tumor cell lines by a cross-reactive human HLA-A2-restricted P53-specific CTL line (English)

1 reference

23 September 2017

P A Würtzen

1

1 reference

23 September 2017

L O Pedersen

series ordinal

2

1 reference

23 September 2017

H S Poulsen

series ordinal

3

1 reference

23 September 2017

M H Claesson

series ordinal

4

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

International Journal of Cancer

23 September 2017

1 reference

23 September 2017

93

1 reference

23 September 2017

6

1 reference

23 September 2017

855-861

1 reference

P53, cell cycle control and apoptosis: implications for cancer

23 September 2017

1 reference

21 January 2018

p53 and human cancers.

1 reference

Immunohistochemical analysis of the p53 oncoprotein on paraffin sections using a series of novel monoclonal antibodies.

21 January 2018

1 reference

p53, a potential target for tumor-directed T cells

21 January 2018

1 reference

Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial

21 January 2018

1 reference

Cancer vaccines based on the identification of genes encoding cancer regression antigens

21 January 2018

1 reference

Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide

21 January 2018

1 reference

Cytotoxic T-lymphocyte clones, established by stimulation with the HLA-A2 binding p5365-73 wild type peptide loaded on dendritic cells In vitro, specifically recognize and lyse HLA-A2 tumour cells overexpressing the p53 protein

21 January 2018

1 reference

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell.

21 January 2018

1 reference

Help for cytotoxic-T-cell responses is mediated by CD40 signalling.

21 January 2018

1 reference

Dendritic cell secretion of IL-15 is induced by recombinant huCD40LT and augments the stimulation of antigen-specific cytolytic T cells

21 January 2018

1 reference

HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides

21 January 2018

1 reference

In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53.

21 January 2018

1 reference

Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands

21 January 2018

1 reference

21 January 2018

1 reference

Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology

21 January 2018

1 reference

Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life

21 January 2018

1 reference

Tolerance to p53 by A2.1-restricted cytotoxic T lymphocytes.

21 January 2018

1 reference

The use of HLA A2.1/p53 peptide tetramers to visualize the impact of self tolerance on the TCR repertoire

21 January 2018

1 reference

Identification and design of p53-derived HLA-A2-binding peptides with increased CTL immunogenicity.

21 January 2018

1 reference

Molecular analysis of APC mutations in familial adenomatous polyposis and sporadic colon carcinomas

21 January 2018

1 reference

Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids

21 January 2018

1 reference

Concordance between p53 protein overexpression and gene mutation in a large series of common human carcinomas

21 January 2018

1 reference

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

21 January 2018

1 reference

T cell-mediated cytotoxicity against p53-protein derived peptides in bulk and limiting dilution cultures of healthy donors

21 January 2018

1 reference

The interaction of beta 2-microglobulin (beta 2m) with mouse class I major histocompatibility antigens and its ability to support peptide binding. A comparison of human and mouse beta 2m

21 January 2018

1 reference

Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.1417

1 reference

23 September 2017

1 reference